[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-362427-105":59,"doc-detail-362427-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","de-novo-variants-in-the-splicing-factor-gene-sf3b1-are-associated-with-neurodevelopmental-disorders","De novo variants in the splicing factor gene SF3B1 are associated with neurodevelopmental disorders","","Cohort study of 26 individuals with neurodevelopmental disorders identifies constitutional heterozygous SF3B1 variants, appearing mostly de novo. Patients show global developmental delay with variable neurological and facial dysmorphic traits. Predicted loss-of-function variants and missense variants form a clinical split, with missense variants linked to more severe, syndromic phenotypes including cardiac and gastrointestinal anomalies. Functional complementation indicates missense variants do not abolish SF3B1 protein function. Targeted and genome-wide RNA splicing analyses show moderated effects on canonical and alternative splicing distinct from somatic cancer variants.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/de-novo-variants-in-the-splicing-factor-gene-sf3b1-are-associated-with-neurodevelopmental-disorders/362427/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/de-novo-variants-in-the-splicing-factor-gene-sf3b1-are-associated-with-neurodevelopmental-disorders/362427.png","ImageObject",300,407,{"name":92,"@type":93},"Jake","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-03","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":39},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What SF3B1 variants are described in individuals with neurodevelopmental disorders?","Question",{"text":112,"@type":113},"The study reports constitutional heterozygous SF3B1 variants that appeared mostly de novo in 26 individuals. Variants include predicted loss-of-function and missense classes.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How do missense variants in SF3B1 differ from loss-of-function variants clinically?",{"text":117,"@type":113},"A dichotomy is observed: missense variants are associated with a more severe, syndromic phenotype, including heart and gastrointestinal anomalies, compared with predicted loss of function.",{"name":119,"@type":110,"acceptedAnswer":120},"Do de novo SF3B1 missense variants eliminate SF3B1 protein function?",{"text":121,"@type":113},"Functional complementation assays indicate that these de novo SF3B1 missense variants did not cause a loss of function of the protein.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},362427,1790966330,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":39,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},962084928904,"https://ap-avatar.wpscdn.com/davatar_155a257f0dc6eb9ab79c44ca47cae57d","Article [https://doi.org/10.1038/s41467-026-68284-9](https://doi.org/10.1038/s41467-026-68284-9)  \nDe novo variants in the splicing factor gene SF3B1 are associated with neurodevelopmental disorders  \nReceived: 18 December 2024  \n\n| Accepted: 31 December 2025 |\n| --- |\n| |\n| Check for updates |\n\nA list of authors and their afﬁliations appears at the end of the paper  \nSF3B1 is an essential and ubiquitous splicing factor that plays a pivotal role in the early steps ofpre-mRNA splicing. Recurrent somatic missense mutations in SF3B1 are frequent in cancers, but no constitutional variant has been reported so far. We describe here a cohort of 26 individuals with neurodevelopmental disorders, harbouring SF3B1 constitutional heterozygous variants that appeared mostly de novo. Patients present with a global developmental delay, associated with variable neurological and facial dysmorphic traits. A dichotomy may emerge between patients harbouring predicted loss of function (n =9) and missense variants (n = 17), the latter being associated with a more severe and syndromic phenotype, including heart and gastrointestinal anomalies. We focused on de novo SF3B1 missense variants, which were largely distinct from those reported in cancer. Functional complementation assays show that de novo SF3B1 missense variants did not cause a loss of function of the protein. Targeted and genome-wide analysis of RNA splicing reveal that they affect canonical and alternative splicing more moderately than somatic variants, and subtly modify the splicing of many transcripts. These ﬁndings place SF3B1 among the rare U2 snRNP components implicated in both cancer and neurodevelopmental disorders, highlighting its critical and multifaceted role in human disease.  \nRNA splicing is a crucial process in eukaryotes where introns are excised from a nascent pre-messenger RNA (pre-mRNA), and adjacent exons are joined to form a mature mRNA. Alternative RNA splicing is a complex and highly regulated mechanism that widely diversiﬁes the proteome by creating multiple proteins from a single gene1. In humans, most introns are recognized and excised by the major spliceosome, which consists of a large and dynamic ribonucleoprotein (RNP) complex including small nuclear RNAs (U1, U2, U4/U6 and U5), in interaction with auxiliary proteins. The spliceosome assembly relies on sequential and dynamic RNA-RNA interactions between U2 and U6 small nuclear RNA (snRNA), and between snRNAs and intronic splice sites2. Disruption in spliceosome components due to genetic variants lead to disorders referred to as spliceosomopathies3.  \nSF3B1 (Splicing factor 3b, subunit 1) is an essential, ubiquitously abundant protein, which plays a pivotal role in the early steps of premRNA splicing, by stabilising the U2 snRNP complex at branch point (BP) sequences. SF3B1 is the largest subunit of SF3b, a heptameric protein complex of U2 snRNP. SF3B1 comprises an unstructured N-terminal domain and a conserved highly structured C-terminal domain called HEAT (Huntington Elongation Factor 3 protein, phosphatase 2 A and the yeast PI3-kinase TOR1), composed of 20 repeats4. SF3B1 is the most frequently mutated RNA splicing factor across cancers, notably in haematological malignancies5 including myelodysplastic neoplasms6 and chronic lymphocytic leukaemia, as well as in solid tumours, such as uveal melanoma7, breast and pancreatic cancers. Until now, only somatic cancer-associated variants of SF3B1 have been reported. They are essentially missense heterozygous variants  \n e-mail: [delphine.bernard@univ-brest.fr](delphine.bernard@univ-brest.fr)  \nresulting in recurrent amino acid substitutions in the H4-H8 repeats of the HEAT domain, with K700E hotspot being the most frequent4. RNAseq studies conducted in various cancers have shown that SF3B1 somatic variants are change-of-function variants that alter canonical and alternative splicing through the recognition of cryptic BP and the use of cryptic or alternative3’ splic","cbCaibGo0rXxiJIf","https://ap.wps.com/l/cbCaibGo0rXxiJIf","pdf",6426192,17,"English","# Background\n## SF3B1 and pre-mRNA splicing\n## Spliceosome disruption and spliceosomopathies\n# Study findings\n## Cohort of individuals with NDD\n## Predicted loss of function vs missense variants\n## Functional complementation and splicing effects\n# Context and implications\n## Relationship to cancer-associated SF3B1 variants\n## Genetic diagnosis of NDD and spliceosome gene involvement","[{\"question\":\"What SF3B1 variants are described in individuals with neurodevelopmental disorders?\",\"answer\":\"The study reports constitutional heterozygous SF3B1 variants that appeared mostly de novo in 26 individuals. Variants include predicted loss-of-function and missense classes.\"},{\"question\":\"How do missense variants in SF3B1 differ from loss-of-function variants clinically?\",\"answer\":\"A dichotomy is observed: missense variants are associated with a more severe, syndromic phenotype, including heart and gastrointestinal anomalies, compared with predicted loss of function.\"},{\"question\":\"Do de novo SF3B1 missense variants eliminate SF3B1 protein function?\",\"answer\":\"Functional complementation assays indicate that these de novo SF3B1 missense variants did not cause a loss of function of the protein.\"}]","De novo variants in the splicing factor gene SF3B1 are associated with neurodevelopmental disorders | PDF",1790147664,43,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/405b60cf84c76ad93960dbc4812c61d5.webp",983,1305,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/3343cc0222d48ee311431820b38d5f03.webp",982,1304,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/039bb238a3f453e5efa8edfb03b2b1d4.webp",981,1303,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/33620400f80a12c9302b80666bbe3e52.webp",980,1301]